penewbie
Registered
I thought I'd being this to your attention, especially after the recent Cagri fibril frenzy fracas.
Ely Lilly has been busy creating their own Amylin analogue, called Eloralintide (LY3841136), currently undergoing phase 1 and 2 trials, both alone and in combination with Tirzepatide for treatment of Diabetes and Obesity.
trials.lilly.com
trials.lilly.com
trials.lilly.com
Now, I have no idea whether Eloralintide is any safer than Cagri, and even if it is, no vendor offers it, for now, anyway. But I thought this was an interesting topic to know about.
Ely Lilly has been busy creating their own Amylin analogue, called Eloralintide (LY3841136), currently undergoing phase 1 and 2 trials, both alone and in combination with Tirzepatide for treatment of Diabetes and Obesity.

Find Lilly Clinical Trials | Learn About Our Research
New medicines are made possible by clinical research volunteers. Search to find a Lilly clinical trial near you. Explore medical research.


Find Lilly Clinical Trials | Learn About Our Research
New medicines are made possible by clinical research volunteers. Search to find a Lilly clinical trial near you. Explore medical research.


Find Lilly Clinical Trials | Learn About Our Research
New medicines are made possible by clinical research volunteers. Search to find a Lilly clinical trial near you. Explore medical research.

Now, I have no idea whether Eloralintide is any safer than Cagri, and even if it is, no vendor offers it, for now, anyway. But I thought this was an interesting topic to know about.
Last edited: